Sarissa Biomedical Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

Sarissa Biomedical General Information

Description

Manufacturer and developer of a hand-held point-of-care diagnostic device designed to identify people who are having a stroke. The company's device is a point-of-care test that uses finger-prick blood samples which are then directed, monitored, and controlled by software, enabling healthcare providers to use them in the measurement of the purines and other neurochemicals, as indicators of neurological activity or disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Acquirer
Zimmer & Peacock
Corporate Office
  • C/O James Cowper Kreston, 1-4 Cumberland Place
  • The White Building
  • Southampton SO15 2NP
  • England, United Kingdom
+44 024 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sarissa Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Merger/Acquisition 28-May-2021 00.000 Completed Generating Revenue
15. Later Stage VC 20-May-2020 00.000 00.000 00.000 Completed Generating Revenue
14. Later Stage VC 08-Mar-2019 00000 00.00 00.000 Completed Generating Revenue
13. Grant 17-May-2018 00.000 00.000 Completed Generating Revenue
12. Later Stage VC 12-Dec-2017 00000 00.000 00.000 Completed Generating Revenue
11. Later Stage VC 31-Mar-2017 00000 00.000 00.000 Completed Generating Revenue
10. Grant 04-Jul-2016 00000 00.000 Completed Generating Revenue
9. Grant 01-Mar-2016 00000 00.000 Completed Startup
8. Later Stage VC 22-Dec-2015 $238K $1.65M 00.000 Completed Startup
7. Grant 01-Oct-2014 $24.4K $1.41M Completed Startup
To view Sarissa Biomedical’s complete valuation and funding history, request access »

Sarissa Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 128,138 $0.012348 $2.73 $2.73 1x $2.73 12.88%
Preference 84,779 $0.012348 $2.73 $2.73 1x $2.73 8.52%
To view Sarissa Biomedical’s complete cap table history, request access »

Sarissa Biomedical Patents

Sarissa Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201614893-D0 Apparatus and methods for measuring biological analytes in a liquid Inactive 02-Sep-2016
US-10889846-B2 Methods and devices to detect the presence of a condition associated with atp depletion in a subject Active 09-Jun-2015 000000000 0
GB-201509974-D0 Methods and device to detect the presence of ischaemia in a subject Inactive 09-Jun-2015 000000000
US-10907189-B2 Methods and devices to detect stroke in a subject Active 09-Jun-2015 000000000 0
US-20180155754-A1 Methods and devices to detect the presence of a condition associated with atp depletion in a subject Active 09-Jun-2015 C12Q1/005
To view Sarissa Biomedical’s complete patent history, request access »

Sarissa Biomedical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sarissa Biomedical Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advantage West Midlands Government 000 0000 000000 0
EarlyStage.nyc Fund Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Innovate UK Accelerator/Incubator 000 0000 000000 0
Mercia Asset Management Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Sarissa Biomedical FAQs

  • When was Sarissa Biomedical founded?

    Sarissa Biomedical was founded in 2002.

  • Who is the founder of Sarissa Biomedical?

    Nicholas Dale Ph.D and E. Llaudet are the founders of Sarissa Biomedical.

  • Where is Sarissa Biomedical headquartered?

    Sarissa Biomedical is headquartered in Southampton, United Kingdom.

  • What is the size of Sarissa Biomedical?

    Sarissa Biomedical has 15 total employees.

  • What industry is Sarissa Biomedical in?

    Sarissa Biomedical’s primary industry is Diagnostic Equipment.

  • Is Sarissa Biomedical a private or public company?

    Sarissa Biomedical is a Private company.

  • What is Sarissa Biomedical’s current revenue?

    The current revenue for Sarissa Biomedical is 000000.

  • How much funding has Sarissa Biomedical raised over time?

    Sarissa Biomedical has raised $5.18M.

  • Who are Sarissa Biomedical’s investors?

    Advantage West Midlands, EarlyStage.nyc Fund, Horizon 2020 SME Instrument, Innovate UK, and Mercia Asset Management are 5 of 12 investors who have invested in Sarissa Biomedical.

  • When was Sarissa Biomedical acquired?

    Sarissa Biomedical was acquired on 28-May-2021.

  • Who acquired Sarissa Biomedical?

    Sarissa Biomedical was acquired by Zimmer & Peacock.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »